Lawrence P. Wennogle, Vice President, Drug Discovery at Intra-Cellular Therapies, Inc. (ITCI), sold 3,604 shares at $15.00 ($54K) on 2014-10-13, disclosed to the SEC on 2014-10-15.
Scheduled sale ($54k) by Vice President, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 1,600 | $24K | 44.4% |
| 2 | $15.00 | 2,004 | $30K | 55.6% |
| Total | $15.00 avg | 3,604 | $54K | 100% |
| Filing → |
| ITCI | SELL | 2014-10-10 | $71K | — | Filing → |
| ITCI | SELL | 2014-10-07 | $247K | — | Filing → |
| ITCI | SELL | 2014-09-17 | $75K | — | Filing → |